Health Minister Theresa Oswald announced today that the drugs include medications for stroke prevention, psoriasis and hepatitis C and diabetes testing supplies.
The minister noted, since 1999, approximately 3,000 new drugs have been added to the pharmacare program.
The drugs include Pradax and Xarelto for prevention of stroke and systemic embolism in patients with atrial fibrillation; Stelara for psoriasis; Victrelis and Victrelis Triple for hepatitis C; and Zelboraf for the treatment of skin cancer.
Coverage is also being added for products used in the treatment of diabetes including the Accu-Chek Mobile Blood Glucose Test Cassette, Ulticare Pen Needles 32 Gauge and a variety of test strips.
Oswald says dozens of additional generic drugs have also been added to pharmacare today, which are available at a lower price than the brand-name alternatives, saving both pharmacare and patients money.